Inventor
SENGUPTA SHILADITYA
US23 patents
⚠️ This page may combine multiple inventors who share the name “SENGUPTA SHILADITYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRIGHAM & WOMENS HOSPITAL INC
6 patentsUS10300143B2May 28, 2019
Compositions for treating cancer and methods for making the same
BRIGHAM & WOMENS HOSPITAL INC8 citations81
US9789193B2Oct 17, 2017
Compositions for treating cancer and methods for making the same
BRIGHAM & WOMENS HOSPITAL INC3 citations70
US10905781B2Feb 2, 2021
Reporter platform for real time monitoring of drug efficacy
BRIGHAM & WOMENS HOSPITAL INC0 citations61
US10300070B2May 28, 2019
Metabolically-activated drug conjugates to overcome resistance in cancer therapy
BRIGHAM & WOMENS HOSPITAL INC1 citations57
US10813931B2Oct 27, 2020
Methods and compositions relating to the treatment of cancer
BRIGHAM & WOMENS HOSPITAL INC0 citations49
US10512696B2Dec 24, 2019
Nanoscale platinum compounds and methods of use thereof
BRIGHAM & WOMENS HOSPITAL INC0 citations44
AKAMARA THERAPEUTICS INC
6 patentsUS10533059B2Jan 14, 2020
Targeted drug delivery through affinity based linkers
AKAMARA THERAPEUTICS INC2 citations66
US12357699B2Jul 15, 2025
B-cell immunotherapy in cancer treatment
AKAMARA THERAPEUTICS INC0 citations57
US11701429B2Jul 18, 2023
Targeted drug delivery through affinity based linkers
AKAMARA THERAPEUTICS INC0 citations56
US11554175B2Jan 17, 2023
Evaluation and optimization of supramolecular therapeutics
AKAMARA THERAPEUTICS INC0 citations43
US10730899B2Aug 4, 2020
Lipid-based platinum compounds and nanoparticles
AKAMARA THERAPEUTICS INC0 citations42
US10081648B2Sep 25, 2018
Lipid-based platinum compounds and nanoparticles
AKAMARA THERAPEUTICS INC0 citations40
INVICTUS ONCOLOGY PVT LTD
3 patentsUS9884123B2Feb 6, 2018
Ligand-targeted molecules and methods thereof
INVICTUS ONCOLOGY PVT LTD4 citations68
US10426753B2Oct 1, 2019
Supramolecular combinatorial therapeutics
INVICTUS ONCOLOGY PVT LTD2 citations62
US10736968B2Aug 11, 2020
Cellular signalling inhibitors, their formulations and methods thereof
INVICTUS ONCOLOGY PVT LTD0 citations43